Navigation Links
Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
Date:11/6/2007

Health's National Kidney Disease Education Program (NKDEP), and National Heart, Lung, and Blood Institute (NHLBI), which all recommend annual microalbumin testing to check and follow this marker of kidney damage among patients with hypertension, diabetes, CVD, and other CKD risk factors.

A slightly elevated level of protein in the urine, or microalbuminuria, is one of the earliest markers of kidney disease. The microalbumin test can detect kidney damage when no other symptoms are present, and provides information that can help physicians and their patients determine treatment that can potentially slow disease progression.

The report is based on findings from 6.2 million estimated Glomerular Filtration Rate (eGFR) test and microalbumin test results, two key indicators of kidney function, performed by Quest Diagnostics between November 2005 and October 2006 on 5.2 million patients who saw a healthcare professional. Among patients who had an eGFR result, approximately 19 percent had a reading of <60 mL/min/1.73 m, an indicator of kidney disease.

An estimated 20 million Americans -- or 1 in 9 adults -- have CKD, which causes kidney damage. Clinical evidence has shown that early detection and treatment of CKD can slow or prevent the progression of the disease to chronic kidney failure, as well as reduce the risk of heart attack, stroke and death. Deaths from CKD have increased 52 percent over the last 16 years.

A second analysis looked at the relationship among CKD, diabetes and hyperlipidemia. This analysis found that of approximately 500,000 test results from people with diabetes or CVD, patients in the early stages of CKD have higher hemoglobin A1c (HbA1c) levels. Elevated HbA1c values indicate inadequate blood sugar control and risk for chronic complications associated with diabetes, such as CKD. These patients are also less likely to achieve LDL-cholesterol, or "bad" cholesterol, goals than patients with advanced CKD. The tests used in this a
'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
3. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
4. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
5. Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children
6. VioQuest Pharmaceuticals Completes Enrollment of Phase I Trial of Lenocta(TM)
7. Two Point of Care Tests From Quest Diagnostics Receive FDA 510(k) Clearance
8. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
9. Roche Diagnostics HIV Viral Load Test Used in Clinical Trials for Isentress, a New Class of HIV Drug
10. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
11. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... N.J. , March 26, 2015 IGI ... Jersey based specialty generic pharmaceutical company, today ... application (ANDA) to the U.S. Food and Drug Administration ... of ANDA submissions now pending at the FDA to ... CEO of the Company, commented, "On March 2, 2015, ...
(Date:3/26/2015)...  CNBC profiled MJ Freeway , a business software ... "How I Did It," which features companies with unique paths ... released yesterday, illustrates how two tech entrepreneurs from ... the marijuana industry. ... Poinsett and Jessica Billingsley used their experience in ...
(Date:3/26/2015)... 26, 2015 Editor Note: ... bottom . Investor-Edge has initiated coverage on ... Salix Pharmaceuticals Ltd (NASDAQ: SLXP ), Hospira Inc. ... ), and Akorn Inc. (NASDAQ: AKRX ). Free ... http://get.Investor-Edge.com/pdf/?c=Mylan&d=26-Mar-2015&s=MYL . The US markets declined on Wednesday, March ...
Breaking Medicine Technology:IGI Laboratories, Inc. Announces First ANDA Submission Of 2015 2MJ Freeway, Industry-Leading Software Solution for Cannabis Businesses, Featured in CNBC Special "How I Did It" 2Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 2Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 3Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 4Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 5
... LITTLE FALLS, N.J., Feb. 2, 2011 Projects ... provider of continuing medical education (CME/CE) activities, previously ... game-changing Living Medical eTextbook. Now the iPhone app ... recognized by iMedicalApps ( www.imedicalapps.com ) as one ...
... and PRINCETON, N.J., Feb. 2, 2011 Eli Lilly ... Squibb Company (NYSE: BMY ) announced today ... two global Phase III studies evaluating necitumumab, an investigational ... cell lung cancer (NSCLC). (Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO) ...
Cached Medicine Technology:Living Medical eTextbook iPhone App from Projects In Knowledge® Named to Top 20 List of Free Medical Apps 2Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 2Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 3Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 4Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 5Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 6Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 7Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 8Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 9Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 10
(Date:3/27/2015)... San Diego, CA (PRWEB) March 27, 2015 ... will launch its Protect Our Children (POC) NOW! vitamin ... at the Medical University of South Carolina (MUSC), and ... POC will be available at no cost to a ... less gestation who live within these two service areas. ...
(Date:3/27/2015)... 27, 2015 When struck with the ... to know where to begin. The latest eBook ... accident attorney, offers accident victims a clear and concise ... to ensure their personal injury claim is seen through ... the first actions that should be taken immediately following ...
(Date:3/27/2015)... Trail mix is the perfect, healthy snack for families on ... the game! It’s portable, lightweight and provides a wide range ... new line of specialty trail mixes that satisfy your hunger ... with nutritious, 100% all natural ingredients. , These tasty combinations ... and fiber to your diet and boost energy. The mixes ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 Approximately ... for Healthy Kids Coalition Lobby Day to lobby ... Health Improvement Program (SHIP). Everlast Climbing was ... PE Bill SF343/HF498 which would strengthen physical education ... student assessments and other measures to strengthen physical ...
(Date:3/27/2015)... Since September 2014, the country singer has been traveling ... been in retirement for a period of 13 years. Many ... to touring, and concert events have been booking quickly in ... out for the two shows recently scheduled for May 8 ... inventory of discounted Garth Brooks tickets for sale. , The ...
Breaking Medicine News(10 mins):Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 3Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 4Health News:Dax Jones Updated eBook on Trucking Accidents Offers Helpful Information to Crash Victims 2Health News:Aurora Product, Inc. Introduces New Line of Specialty Trail Mixes 2Health News:Everlast Climbing Advocates to Strengthen Physical Education in Minnesota Schools 2Health News:Garth Brooks Tickets for Omaha: BuyCheapTicketsToEvents.com Draws Customers by Discounting Prices on 2015 Tickets for Garth Brooks’ Tour Stops at CenturyLink Center 2
... Weinberg is the first recipient of the science prize inaugurated ... Eva Klein. The prize is awarded in person by Crown ... 2008. The prizewinner, who is to be a leading international ... Institutet in Stockholm for two weeks to give lectures and ...
... You Be Ready with that Confident ... ... Freshening Teeth Cleaners, an effective way to,clean teeth and freshen breath on-the-go. ... of,teeth, leaving them feeling smooth and clean., A great smile is ...
... /PRNewswire/ - There is new hope for vertigo,and ... DizzyFIX,patients with vertigo can now treat themselves. Studies ... visual device helps treat the most common,type of ... DizzyFIX has received a number of medical research ...
... Sequences of DNA in the human genome that originated ... our bodies and are even essential for a healthy ... of Microbiology Today. , Retrovirus infections represent the most ... its genome into the DNA of the host cell, ...
... REDWOOD CITY, Calif., Jan. 29 Maxygen, Inc.,(Nasdaq: ... of,improved protein drugs, will host a conference call to ... results at 11:30 a.m.,ET (8:30 a.m. PT) on Tuesday, ... host the call. A press release announcing,Maxygen,s fourth quarter ...
... Gross Proceeds Expected to Be Approximately $168.6 Million, ... or the "Company") announced today that it has agreed ... Investment Bank, as sole,underwriter, in an underwritten public offering. ... option to purchase up to an additional,585,000 shares of ...
Cached Medicine News:Health News:Kimberly-Clark Launches DentaBurst(TM) Freshening Teeth Cleaners 2Health News:All Star Sales Introduces DizzyFIX a New Treatment for Vertigo and Dizziness 2Health News:Maxygen to Host Fourth Quarter and Year End 2007 Financial Results Conference Call on February 12, 2008 2Health News:Ventas Enters Agreement to Sell Common Stock 2Health News:Ventas Enters Agreement to Sell Common Stock 3Health News:Ventas Enters Agreement to Sell Common Stock 4Health News:Ventas Enters Agreement to Sell Common Stock 5
... ORTHOSET Radiopaque Bone Cement ... system: a sterile,ampule containing bone ... pack, and a sterile polyethylene ... a peelable pouch. The interiors ...
Antibiotics (Gentamicin) loaded, low viscosity bone cement for syringe use with an average setting time of approx. 7-9 Min., 41.6g of powder and 16.4g of liquid....
... Featuring new technology, such as a ... shaft and lens housings, this arthroscope has ... accomplished by EO, Steris and steam autoclaving ... diameters. Light post/adapters to fit ACMI, Wolf, ...
... The Passport II delivery device is the ... for C11UB. Its simple-to-use syringe technology allows ... a small incision. The blue colored plunger ... to protect the haptics during insertion. The ...
Medicine Products: